Infusion of CD34+ cells in patients with chronic kidney disease improved 1-year outcome32 and CD34+ and CD133+ stem cells infusion has been used as a supportive treatment for end-stage liver disease with satisfactory tolerability.33 This evidence concerns the gene CD34 and chronic kidney disease.